NCT04478851 EXCEL: Exercise for Cancer to Enhance Living Well
| NCT ID | NCT04478851 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Calgary |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2020-09-02 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,500 participants in total. It began in 2020-09-02 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Project EXCEL will provide community or online exercise programs to rural and remote and under-served cancer survivors, as well as encourage participants to become life-long exercisers. Exercise is an evidence-based self-management strategy that benefits all cancer survivors. However, most cancer survivors who live in remote or rural places don't have adequate opportunities to be involved in exercise programs that are tailored to their needs.
Eligibility Criteria
Inclusion Criteria: * have a diagnosis of cancer * are over the age of 18 years * are able to participate in mild levels of activity * are about to have treatment, are currently having treatment, or have had cancer treatment within the last 5 years * can read/write in English * can access online programs, if necessary, to participate in the exercise programs. Exclusion Criteria: * unable to read/write in English * are unable to participate in exercise * for online programs, do not have internet or computer access
Contact & Investigator
Nicole Culos-Reed, PhD
PRINCIPAL INVESTIGATOR
University of Calgary
Frequently Asked Questions
Who can join the NCT04478851 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04478851 currently recruiting?
Yes, NCT04478851 is actively recruiting participants. Contact the research team at nculosre@ucalgary.ca for enrollment information.
Where is the NCT04478851 trial being conducted?
This trial is being conducted at Calgary, Canada, Edmonton, Canada, Halifax, Canada.
Who is sponsoring the NCT04478851 clinical trial?
NCT04478851 is sponsored by University of Calgary. The principal investigator is Nicole Culos-Reed, PhD at University of Calgary. The trial plans to enroll 1,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.